Literature DB >> 33474677

Estimation of influenza-attributable burden in primary care from season 2014/2015 to 2018/2019, France.

Morgane Paternoster1, Shirley Masse2, Sylvie van der Werf3, Bruno Lina4, Daniel Levy-Bruhl5, Natacha Villechenaud2, Martine Valette4, Sylvie Behillil3, Sibylle Bernard-Stoecklin5, Caroline Guerrisi1, Thierry Blanchon1, Alessandra Falchi2, Thomas Hanslik1,6,7, Clément Turbelin1, Cécile Souty8.   

Abstract

Influenza viruses cause seasonal epidemics whose intensity varies according to the circulating virus type and subtype. We aim to estimate influenza-like illness (ILI) incidence attributable to influenza viruses in France from October 2014 to May 2019. Physicians participating in the French Sentinelles network reported the number of patients with ILI seen in consultation and performed nasopharyngeal swabs in a sample of these patients. The swabs were tested by RT-PCR for the presence of influenza viruses. These clinical and virological data were combined to estimate ILI incidence attributable to influenza viruses by subtypes and age groups. Influenza incidence rates over seasons ranged from 1.9 (95% CI, 1.9; 2.0) to 3.4% (95% CI, 3.2; 3.6) of the population. Each season, more than half of ILI cases were attributable to influenza. Children under 15 years were the most affected, with influenza incidence rates ranging from 3.0 (95% CI, 2.8;3.3) to 5.7% (95% CI, 5.3;6.1). Co-circulation of several (sub)types of influenza viruses was observed each year, except in 2016/2017 where A(H3N2) viruses accounted for 98.0% of the influenza cases. Weekly ILI incidences attributable to each influenza virus (sub)type were mostly synchronized with ILI incidence, except in 2014/2015 and 2017/2018, where incidence attributable to type B viruses peaked few weeks later. The burden of medically attended influenza among patients with ILI is significant in France, varying considerably across years and age groups. These results show the importance of influenza surveillance in primary care combining clinical and virological data.

Entities:  

Keywords:  Influenza; Influenza-like illness (ILI); Primary care; Surveillance

Year:  2021        PMID: 33474677     DOI: 10.1007/s10096-021-04161-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

Review 1.  Influenza.

Authors:  Catharine Paules; Kanta Subbarao
Journal:  Lancet       Date:  2017-03-13       Impact factor: 79.321

Review 2.  Virtual surveillance of communicable diseases: a 20-year experience in France.

Authors:  A Flahault; T Blanchon; Y Dorléans; L Toubiana; J F Vibert; A J Valleron
Journal:  Stat Methods Med Res       Date:  2006-10       Impact factor: 3.021

3.  Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France.

Authors:  F Carrat; A Tachet; C Rouzioux; B Housset; A J Valleron
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

4.  Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13.

Authors:  Ashley Fowlkes; Andrea Steffens; Jon Temte; Steve Di Lonardo; Lisa McHugh; Karen Martin; Heather Rubino; Michelle Feist; Carol Davis; Christine Selzer; Jose Lojo; Oluwakemi Oni; Katie Kurkjian; Ann Thomas; Rachelle Boulton; Nicole Bryan; Ruth Lynfield; Matthew Biggerstaff; Lyn Finelli
Journal:  Lancet Respir Med       Date:  2015-08-21       Impact factor: 30.700

5.  Influenza-attributable burden in United Kingdom primary care.

Authors:  D M Fleming; R J Taylor; F Haguinet; C Schuck-Paim; J Logie; D J Webb; R L Lustig; G Matias
Journal:  Epidemiol Infect       Date:  2015-07-13       Impact factor: 2.451

6.  Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017.

Authors:  Lasse S Vestergaard; Jens Nielsen; Tyra G Krause; Laura Espenhain; Katrien Tersago; Natalia Bustos Sierra; Gleb Denissov; Kaire Innos; Mikko J Virtanen; Anne Fouillet; Theodore Lytras; Anna Paldy; Janos Bobvos; Lisa Domegan; Joan O'Donnell; Matteo Scortichini; Annamaria de Martino; Kathleen England; Neville Calleja; Liselotte van Asten; Anne C Teirlinck; Ragnhild Tønnessen; Richard A White; Susana P Silva; Ana P Rodrigues; Amparo Larrauri; Inmaculada Leon; Ahmed Farah; Christoph Junker; Mary Sinnathamby; Richard G Pebody; Arlene Reynolds; Jennifer Bishop; Diane Gross; Cornelia Adlhoch; Pasi Penttinen; Kåre Mølbak
Journal:  Euro Surveill       Date:  2017-04-06

7.  Influenza epidemics observed in primary care from 1984 to 2017 in France: A decrease in epidemic size over time.

Authors:  Cécile Souty; Philippe Amoros; Alessandra Falchi; Lisandru Capai; Isabelle Bonmarin; Sylvie van der Werf; Shirley Masse; Clément Turbelin; Louise Rossignol; Ana-Maria Vilcu; Daniel Lévy-Bruhl; Bruno Lina; Laëtitia Minodier; Yves Dorléans; Caroline Guerrisi; Thomas Hanslik; Thierry Blanchon
Journal:  Influenza Other Respir Viruses       Date:  2019-01-18       Impact factor: 4.380

8.  Estimating influenza incidence and rates of influenza-like illness in the outpatient setting.

Authors:  Ashley Fowlkes; Sharoda Dasgupta; Edward Chao; Jennifer Lemmings; Kate Goodin; Meghan Harris; Karen Martin; Michelle Feist; Winfred Wu; Rachelle Boulton; Jonathan Temte; Lynnette Brammer; Lyn Finelli
Journal:  Influenza Other Respir Viruses       Date:  2012-09-18       Impact factor: 4.380

9.  Estimation of influenza-attributable medically attended acute respiratory illness by influenza type/subtype and age, Germany, 2001/02-2014/15.

Authors:  Matthias An der Heiden; Udo Buchholz
Journal:  Influenza Other Respir Viruses       Date:  2016-11-18       Impact factor: 4.380

10.  Baseline characteristics and clinical symptoms related to respiratory viruses identified among patients presenting with influenza-like illness in primary care.

Authors:  C Souty; S Masse; M Valette; S Behillil; I Bonmarin; C Pino; C Turbelin; L Capai; A M Vilcu; B Lina; S van der Werf; T Blanchon; A Falchi; T Hanslik
Journal:  Clin Microbiol Infect       Date:  2019-01-29       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.